Nikolaos Papanas
Nikolaos Papanas is an expert in Endocrinology at University Hospital of Alexandroupolis (Greece). As of October 2026, ScienceLeadR ranks Nikolaos Papanas in the top 1% of experts worldwide for Diabetic Neuropathies, Diabetes Complications and Skin Ulcer. Nikolaos Papanas has authored 638 publications, the most recent in 2026, and is an investigator in 4 clinical trials. SLR score: 2,032 (community average: 125). How the SLR is computed.
LeadR Profile
Endocrinology
Subspecialties: Pharmacy - Cardiology - Biochemistry
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Short Biography
Organizations
Career arc: 2004 - 2026
Number : 638
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Diabetic Foot: An Unmet Opportunity for the Novel Antidiabetic Agents? PMID 42904905 — foot, diabetic foot | Int J Low Extrem Wounds | 2026 | 0 |
| Diabetic Foot Ulcers and Curcumin. PMID 42862764 — foot, foot ulcer, ulcer, diabetic foot, curcumin | Int J Low Extrem Wounds | 2026 | 0 |
| New Amylin-Based Agonists for the Treatment of Obesity and Type 2 Diabetes Mellitus. PMID 42803913 — diabetes mellitus, glucagon-like peptide-1 receptor, insulin, obesity, weight loss, glucagon, therapeutics, islet amyloid polypeptide, glucagon-like peptides, diabetes mellitus, type 2 | Diabetes Ther | 2026 | 0 |
| Statins in Diabetic Foot Ulcer Healing: From Biological Mechanisms to Clinical Evidence. A Comprehensive Literature Review. PMID 42709491 — diabetes mellitus, vascular endothelial growth factor a, foot, foot ulcer, ulcer, diabetic foot, therapeutics, hydroxymethylglutaryl-coa reductase inhibitors, tissues, angiogenesis | Int J Low Extrem Wounds | 2026 | 0 |
| Assessing the scientific impact of scientists and the role of altmetrics: Realistic goal or utopia? PMID 42678432 | Int J Low Extrem Wounds | 2026 | 0 |
Clinical Studies 4
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
LeadR Networks
Main global connection map